Search Results for: EU

By Kuldip K. Ambastha The stock price of First Republic Bank (FRC), a financial institution, continues to have a bumpy ride, per the table above. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of March 13-17, 2023; By Kuldip K. Ambastha.”) Continued turmoil among American regional banks alongside …

Continue reading “What Caught Our Attention in the Investment World? – Week of March 20-24, 2023”

By Kuldip K. Ambastha On the trading day of Tuesday, November 1, 2022, Johnson & Johnson (JNJ), a major pharmaceutical and medical product provider, announced plans to acquire Abiomed, Inc. (ABMD), a medical device maker. Due to this development, for that day the stock price of Abiomed rose sharply by +49.9% per share, while the …

Continue reading “What Caught Our Attention in the Investment World? – Week of October 31-November 4, 2022”

By Kuldip K. Ambastha The stock of BeiGene, Ltd. (BGNE), a commercial stage biopharmaceutical company focused on cancer treatment drugs, saw a +20.5% increase in price per share on Wednesday, October 12, 2022. Brukinsa (zanubrutinib) in its Phase 3 trial data showed highly positive results in people with chronic lymphocytic leukemia (CLL) or small lymphocytic …

Continue reading “What Caught Our Attention in the Investment World? – Week of October 10-14, 2022”

By Kuldip K. Ambastha The stock of Regeneron Pharmaceuticals, Inc. (REGN), a biotechnology company with a portfolio of medicines for individuals with serious diseases, increased in price by +18.8% per share on the trading day of Thursday, September 8, 2022. Eylea (aka: aflibercept), an anti-blindness eye medication, was the cause of this price run-up, because …

Continue reading “What Caught Our Attention in the Investment World? – Week of September 6-9, 2022”

By Kuldip K. Ambastha On Wednesday, July 27, 2022, the stock of global pharmaceutical company Teva Pharmaceutical Industries Limited (TEVA) rose in price by +28.4% per share. Teva is the world’s largest generic medicine producer, and has been struggling for the last five years because of weakness in the American generic medicine sector plus intense …

Continue reading “What Caught Our Attention in the Investment World? – Week of July 25-29, 2022”

By Kuldip K. Ambastha Novavax, Inc. (NVAX), a clinical-stage vaccine company, had its stock price fall by -17.2% per share on Thursday, June 9, 2022. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of December 27-31, 2021; By Kuldip K. Ambastha.”) In 1Q2022, earnings per share plus total …

Continue reading “What Caught Our Attention in the Investment World? – Week of June 6-10, 2022”

By Kuldip K. Ambastha Novavax, Inc. (NVAX), a clinical-stage vaccine company, had four negative daily returns and one positive daily return for its shares during this past trading week per the table displayed here. Worldwide, the coronavirus pandemic continues to be a serious public health issue, especially through the Delta and Omicron COVID-19 variants. Novavax …

Continue reading “What Caught Our Attention in the Investment World? – Week of December 27-31, 2021”

By Kuldip K. Ambastha In this past trading week, Sweetgreen Inc. (SG), a fast-casual restaurant chain, was revealed to be going public via an initial public offering (IPO) on the New York Stock Exchange (NYSE). This IPO was announced in a Form S-1 document filed with the U.S. Securities and Exchange Commission (SEC), stating that …

Continue reading “What Caught Our Attention in the Investment World? – Week of October 25-29, 2021”

By Kuldip K. Ambastha On Friday, September 3, 2021, the stock of Forte Biosciences, Inc. (FBRX) stood out for its substantial trading day loss of -82.3%. Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on potential treatments for inflammatory skin diseases. The company released results of a Phase 2 clinical trial of FB-401, related …

Continue reading “What Caught Our Attention in the Investment World? – Week of August 30-September 3, 2021”

By Kuldip K. Ambastha Sonoma Pharmaceuticals Inc. (SNOA) is a specialty pharmaceutical company focused on conditions which could be treated using stabilized hypochlorous acid (HOCl or HClO) in various ways. The company’s stock had a volatile end for this past trading week, with a gain of +50.6% on Thursday, August 19, 2021 followed by a …

Continue reading “What Caught Our Attention in the Investment World? – Week of August 16-20, 2021”